Appointment booking for Dr. Michael Fairfax, DO is currently not available.Dr. Michael Fairfax, DO has not yet fully activated their profile on DiabetesIQ.
Dr. Michael Fairfax, DO (he/him) is a Rheumatologist in Gilbert, AZ with over 18 years of experience. What is your opinion of Dr. Michael Fairfax, DO? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Fairfax, DO has received over $3,479 which includes payments from the following companies:
$685.46 from Amgen Inc.
$639.89 from AbbVie, Inc.
$482.95 from LILLY USA, LLC
$282.50 from Pfizer Inc.
$217.88 from GENZYME CORPORATION
$186.29 from Janssen Biotech, Inc.
$157.03 from UCB, Inc.
$152.37 from Genentech USA, Inc.
$146.63 from GlaxoSmithKline, LLC.
$142.00 from Novartis Pharmaceuticals Corporation
$110.20 from Celgene Corporation
$64.11 from Horizon Pharma plc
$63.75 from E.R. Squibb & Sons, L.L.C.
$31.94 from Sobi, Inc
$21.07 from Boston Scientific Corporation
$20.31 from Crealta Pharmaceuticals LLC
$19.57 from Boehringer Ingelheim Pharmaceuticals, Inc.
$18.32 from Medtronic USA, Inc.
$13.48 from Osseon LLC
$12.39 from Radius Health, Inc.
Payments received by Dr. Michael Fairfax, DO were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!